Illumina launches TruSeq sample preparation, Exome Enrichment kits for sequencing studies

Illumina, Inc. (NASDAQ:ILMN) today announced TruSeq sample preparation kits for DNA, RNA, and small RNA applications and the TruSeq Exome Enrichment Kit, for use across the company's portfolio of sequencing platforms. TruSeq sequencing reagents provide a streamlined workflow that is economical and scalable, delivering industry-leading accuracy for sequencing studies.

“The RNA Sample Prep Kit allows us to take full advantage of the increased sequencing output of our Illumina instruments”

"The benefits of TruSeq are critical for our customers who are routinely generating more than 300 Gb per run with their HiSeq systems," said Christian Henry, General Manager of Life Sciences for Illumina. "As we continue to scale the output of our HiSeq systems, the multiplexing capability and economics of TruSeq solutions will become even more important. Illumina is committed to continuing innovation in sequencing to help our customers do more and publish even faster. In fact, the 1,000th study using Illumina sequencing was published in October."

TruSeq Sample Prep kits feature master-mixed reagents and optimized adapter design, making the industry's most simplified sequencing workflow even easier. TruSeq Exome Enrichment kits, used with TruSeq DNA Sample Prep kits, enable large-scale exome studies using a pre-enrichment pooling approach with plate-based processing of up to 96 samples.

"The RNA Sample Prep Kit allows us to take full advantage of the increased sequencing output of our Illumina instruments," said Greg May, President and COO at the National Center for Genomic Resources. "RNA-seq is now cost-competitive with microarrays, allowing the design of reasonably priced, rigorous gene expression experiments with appropriate sample sizes for statistical analysis."

TruSeq solutions provide:

  • Coverage of greater than 62 Mb of the human exome, with an industry-leading price of less than $300 per sample enrichment.
  • A flexible approach for single-end, paired-end, and multiplexed sequencing with as much as 80% reduction in price for sample prep.
  • Sequencing-based gene expression studies with richer data sets, a simpler workflow, and a lower price than arrays.
  • A means for researchers to combine up to 48 samples into a single sequencing lane, profiling the whole spectrum of small RNAs with the highest sensitivity and specificity.

TruSeq Sample Prep kits are available for order and expected to ship later this month. For more information about TruSeq kits or to learn more about Illumina's sequencing workflow solutions, please visit https://www.illumina.com/.

Source: Illumina, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Illumina, Inc.. (2023, March 08). Illumina launches TruSeq sample preparation, Exome Enrichment kits for sequencing studies. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/news/20101103/Illumina-launches-TruSeq-sample-preparation-Exome-Enrichment-kits-for-sequencing-studies.aspx.

  • MLA

    Illumina, Inc.. "Illumina launches TruSeq sample preparation, Exome Enrichment kits for sequencing studies". News-Medical. 31 October 2024. <https://www.news-medical.net/news/20101103/Illumina-launches-TruSeq-sample-preparation-Exome-Enrichment-kits-for-sequencing-studies.aspx>.

  • Chicago

    Illumina, Inc.. "Illumina launches TruSeq sample preparation, Exome Enrichment kits for sequencing studies". News-Medical. https://www.news-medical.net/news/20101103/Illumina-launches-TruSeq-sample-preparation-Exome-Enrichment-kits-for-sequencing-studies.aspx. (accessed October 31, 2024).

  • Harvard

    Illumina, Inc.. 2023. Illumina launches TruSeq sample preparation, Exome Enrichment kits for sequencing studies. News-Medical, viewed 31 October 2024, https://www.news-medical.net/news/20101103/Illumina-launches-TruSeq-sample-preparation-Exome-Enrichment-kits-for-sequencing-studies.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Illumina's board appoints Jacob Thaysen, Ph.D. as its new Chief Executive Officer